Technical Analysis for DAWN - Day One Biopharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 21.25 1.19% 0.25
DAWN closed up 1.19 percent on Monday, June 21, 2021, on 34 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical DAWN trend table...

Date Alert Name Type % Chg
Up 3 Days in a Row Strength 0.00%
Hot IPO Pullback Bullish Swing Setup 1.19%
Multiple of Ten Bullish Other 1.19%
Outside Day Range Expansion 1.19%
Hot IPO Pullback Bullish Swing Setup 9.20%
Narrow Range Bar Range Contraction 9.20%
NR7 Range Contraction 9.20%
Inside Day Range Contraction 9.20%
Hot IPO Pullback Bullish Swing Setup 10.50%
Multiple of Ten Bearish Other 10.50%
Older End-of-Day Signals for DAWN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 8 hours ago
Hot IPO Pullback Entry about 12 hours ago
Rose Above Previous Day's High about 12 hours ago
Up 5% about 12 hours ago
Up 3% about 12 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancers Enzymes Signal Transduction Protein Kinase Inhibitors Protein Kinase Kinase Fibrosarcoma Ym Biosciences

Is DAWN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 27.04
52 Week Low 17.1941
Average Volume 216,539
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 20.39
Average True Range 2.26
ADX 0.0
+DI 12.23
-DI 21.39
Chandelier Exit (Long, 3 ATRs) 20.27
Chandelier Exit (Short, 3 ATRs) 23.96
Upper Bollinger Bands 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line -0.20
MACD Signal Line -0.17
MACD Histogram -0.0283
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.33
Resistance 3 (R3) 23.52 23.01 22.99
Resistance 2 (R2) 23.01 22.48 22.92 22.87
Resistance 1 (R1) 22.13 22.15 21.87 21.94 22.75
Pivot Point 21.62 21.62 21.49 21.53 21.62
Support 1 (S1) 20.74 21.09 20.49 20.56 19.75
Support 2 (S2) 20.23 20.76 20.14 19.63
Support 3 (S3) 19.35 20.23 19.51
Support 4 (S4) 19.17